It’s only February, but my pick for the Worst Biopharma CEO of 2025 has already been decided: Albert Bourla of Pfizer ... the Department of Health and Human Services — have castigated ...

In a year in which he faced down a challenge from an activist investor, Pfizer CEO Albert Bourla, Ph.D., received a 14% total pay increase, according (PDF) to a securities filing. The CEO's ...

Pfizer CEO Dr. Albert Bourla and chair of the PhRMA Board of Directors Pharmaceutical Research and Manufacturers of America (PhRMA) Pfizer CEO Dr. Albert Bourla and chair of the PhRMA Board of ...

Pfizer has promoted Albert Bourla, seen as a likely successor to incumbent CEO Ian Read, to the newly-created role of chief operating officer. The move could help Read focus on long-term strategy ...

Activist investor Starboard Value has launched a broadside against Pfizer's leadership under chief executive Albert ... not, however, deliver any specific demands, such as the removal of Bourla ...

Wednesday, Pfizer CEO Albert Bourla ... beneficial for the pharma industry than not. Speaking at a PhRMA summit in Washington, D.C., on Tuesday, Bourla argued that a second Trump presidency ...

(JTA) — Albert Bourla, the chief executive officer of Pfizer, was named the winner of the 2022 Genesis Prize, the award sometimes called the “Jewish Nobel,” and pledged his winnings to ...

Pfizer Chief Executive Albert Bourla says recent Seagen acquisition provides "tremendous opportunity for growth." This interview was recorded on Jan. 15, 2024, at the World Economic Forum meeting ...

Pfizer CEO Albert Bourla discusses the major mobilization to deliver a Covid-19 vaccine in record speed, and what it means for medical research, with WSJ's health and science coverage chief ...

Pfizer CEO Albert Bourla has revealed ... candidate include that human-made chemicals in water systems could ‘turn’ children gay or transgender and that HIV does not derive from AIDS, as ...